<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Multicellular layers (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>) of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells is an in vitro 3-dimensional (3D) model that mimics avascular microregions of human <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> and has been shown to be useful in pharmacokinetic-pharmacodynamic studies of anticancer agents </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether Ki-67, which is widely used as a proliferation marker, can be used to evaluate changes in proliferative fractions following drug exposure in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> of HT-29 human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>Ki-67 expression was monitored and compared between <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells cultured as monolayers or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Drug distribution and Ki-67 expression were evaluated within <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> following exposure to <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> and paclitaxel </plain></SENT>
<SENT sid="4" pm="."><plain>Ki-67 expression was observed in the nuclei of proliferating cells in monolayers, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> xenograft, and multicellular spheroids </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>, however, Ki-67 expression was detected in the membrane/cytoplasm as well as in the nucleus throughout <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Neither the location nor the level of expression changed following drug exposure, whereas drug-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> increased </plain></SENT>
<SENT sid="7" pm="."><plain>Our data show that membranous/cytoplasmic Ki-67 may not be valid as a marker for the proliferative activity of cells grown as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Studies for non-nuclear localization and its mechanism in 3D in vitro models of other cell lines are warranted </plain></SENT>
</text></document>